Cargando…

Tumorigenesis of Papillary Thyroid Cancer Is Not BRAF-Dependent in Patients with Acromegaly

INTRODUCTION: Several studies have reported a high frequency of papillary thyroid cancer (PTC) in patients with acromegaly. The aim of this study was to determine the prevalence and predictors of thyroid cancer in patients with acromegaly and to investigate the frequency of the BRAF (V600E) mutation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hee Kyung, Lee, Ji Shin, Park, Min Ho, Cho, Jin Seong, Yoon, Jee Hee, Kim, Soo Jeong, Kang, Ho-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201528/ https://www.ncbi.nlm.nih.gov/pubmed/25329702 http://dx.doi.org/10.1371/journal.pone.0110241

Ejemplares similares

The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer
por: Kim, Hee Kyung, et al.
Publicado: (2020)

Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma
por: Lim, Jinsun, et al.
Publicado: (2023)

BRAF(V600E) Positivity-Dependent Effect of Age on Papillary Thyroid Cancer Recurrence Risk
por: Park, Joonseon, et al.
Publicado: (2023)

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
por: Paek, Se Hyun, et al.
Publicado: (2017)

Spontaneous ovarian hyperstimulation syndrome in a young female subject with a lingual thyroid and primary hypothyroidism
por: Kim, Soo Jeong, et al.
Publicado: (2017)

Clinical implication of the BRAF(V600E) mutation in papillary thyroid carcinoma
por: Kim, Yong-Seok, et al.
Publicado: (2013)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

Osteopontin expression in papillary thyroid carcinoma and its relationship with the BRAF mutation and tumor characteristics
por: Kang, Kyung Ho
Publicado: (2013)

A case of masked toxic adenoma in a patient with non-thyroidal illness
por: Cho, Eun Ae, et al.
Publicado: (2014)

AK2 is an AMP-sensing negative regulator of BRAF in tumorigenesis
por: Kim, Hyunjoo, et al.
Publicado: (2022)

Diffuse Metastasis to the Thyroid: Unique Ultrasonographic Finding and Clinical Correlation
por: Kim, Hee Kyung, et al.
Publicado: (2014)

Age and prognosis of papillary thyroid carcinoma: retrospective stratification into three groups
por: Cho, Jin Seong, et al.
Publicado: (2012)

Predicting Extrathyroidal Extension in Patients With Papillary Thyroid Microcarcinoma According to a BRAF Mutation
por: Lee, Doh Young, et al.
Publicado: (2017)

BRAF in Papillary Thyroid Carcinoma
por: Lanzilotta, Salvatore Giovanni, et al.
Publicado: (2007)

Cross-Regulation between Oncogenic BRAF(V600E) Kinase and the MST1 Pathway in Papillary Thyroid Carcinoma
por: Lee, Seong Jin, et al.
Publicado: (2011)

Can Ultrasound Be as a Surrogate Marker for Diagnosing a Papillary Thyroid Cancer? Comparison with BRAF Mutation Analysis
por: Seo, Jae Young, et al.
Publicado: (2014)

Observational study of central metastases following thyroid lobectomy without a completion thyroidectomy for papillary carcinoma
por: Cho, Jin Seong, et al.
Publicado: (2012)

The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma
por: Kong, Joon Seog, et al.
Publicado: (2018)

Acromegaly and papillary thyroid carcinoma: A case series
por: Heidarpour, Maryam, et al.
Publicado: (2019)

Prevalence of BRAF(V600E) Mutation in Follicular Variant of Papillary Thyroid Carcinoma and Non-Invasive Follicular Tumor with Papillary-Like Nuclear Features (NIFTP) in a BRAF(V600E) Prevalent Area
por: Kim, Hyereen, et al.
Publicado: (2018)

Detection of Plasma BRAF(V600E) Mutation Is Associated with Lung Metastasis in Papillary Thyroid Carcinomas
por: Kim, Bo Hyun, et al.
Publicado: (2015)

Characteristics of Immune-Related Thyroid Adverse Events in Patients Treated with PD-1/PD-L1 Inhibitors
por: Yoon, Jee Hee, et al.
Publicado: (2021)

MON-575 Clinical Implication of Sonographic Evaluation for Immune Checkpoint Inhibitor-Related Thyroiditis: A Case Series Study
por: Hong, A Ram, et al.
Publicado: (2019)

Early Thyroid Volume Reduction in Subacute Thyroiditis Can be a Potential Indicator for Hypothyroidism
por: Park, Ji Yong, et al.
Publicado: (2022)

Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation
por: Kim, Seo Ki, et al.
Publicado: (2015)

Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
por: Kim, Sue Youn, et al.
Publicado: (2020)

Proto-oncogene Pokemon in thyroid cancer: a potential promoter of tumorigenesis in papillary thyroid carcinoma
por: Chang, Kyungseek, et al.
Publicado: (2021)

The relationship between the BRAF(V600E) mutation in papillary thyroid microcarcinoma and clinicopathologic factors
por: Choi, Sun Yi, et al.
Publicado: (2013)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
por: Kimbrell, Hillary Z., et al.
Publicado: (2015)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
por: Kim, Woon Won, et al.
Publicado: (2018)

Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
por: Yoon, Jee Hee, et al.
Publicado: (2021)

MON-463 Cilia-Dependent Hedgehog Signaling in Adamantinomatous AND Neutrophil-Related Innate Immune Responses in Papillary Craniopharyngiomas Mediate Tumorigenesis
por: Kim, Jung Hee, et al.
Publicado: (2019)

Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population
por: Cho, Yoon Young, et al.
Publicado: (2020)

Impact of Extranodal Extension on Risk Stratification in Papillary Thyroid Carcinoma
por: Kim, Hye In, et al.
Publicado: (2019)

Radiomics in predicting mutation status for thyroid cancer: A preliminary study using radiomics features for predicting BRAF(V600E) mutations in papillary thyroid carcinoma
por: Yoon, Jung Hyun, et al.
Publicado: (2020)

The Utility of BRAF Testing in the Management of Papillary Thyroid Cancer
por: Melck, Adrienne L., et al.
Publicado: (2010)

A Comprehensive Assessment of the Harms of Fine-Needle Aspiration Biopsy for Thyroid Nodules: A Systematic Review
por: Park, Ji Yong, et al.
Publicado: (2023)

Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age
por: Cho, Jin-Kyu, et al.
Publicado: (2012)

ODP464 Association between preoperative vitamin D insufficiency and postoperative symptomatic hypocalcemia in patients with thyroid cancer
por: Ram Hong, A, et al.
Publicado: (2022)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
por: Chin, Sang Ouk, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4mp7b7mpgn9g15gc6qseh0j742